Works by Roberts, Matthew J.


Results: 96
    1
    2
    3
    4

    Testicular Torsion: Not Just in Young Men.

    Published in:
    Journal of Urological Surgery, 2022, v. 9, n. 3, p. 215, doi. 10.4274/jus.galenos.2021.2021.0085
    By:
    • Saad, Jeremy;
    • Shanmugasundaram, Ramesh;
    • Heywood, Sean;
    • Varol, Celi;
    • Roberts, Matthew J.
    Publication type:
    Article
    5

    Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 1, p. 94, doi. 10.2967/jnumed.123.266164
    By:
    • Emmett, Louise;
    • Pa, Nathan;
    • Counter, William;
    • Calais, Jeremie;
    • Barbato, Francesco;
    • Burger, Irene;
    • Eiber, Matthias;
    • Roberts, Matthew J.;
    • Agrawal, Shikha;
    • Franklin, Anthony;
    • Xue, Alan;
    • Rasiah, Krishan;
    • John, Nikeith;
    • Moon, Daniel;
    • Frydenberg, Mark;
    • Yaxley, John;
    • Stricker, Phillip;
    • Wong, Keith;
    • Coughlin, Geoff;
    • Gianduzzo, Troy
    Publication type:
    Article
    6

    Drugs for benign prostatic hypertrophy.

    Published in:
    Australian Prescriber, 2018, v. 41, n. 5, p. 150, doi. 10.18773/austprescr.2018.045
    By:
    • Jiwrajka, Manasi;
    • Yaxley, William;
    • Ranasinghe, Sachinka;
    • Perera, Marlon;
    • Roberts, Matthew J.;
    • Yaxley, John
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 51, n. 1, p. 295, doi. 10.1007/s00259-023-06380-4
    By:
    • Pathmanathan, Shivanshan;
    • Tariq, Arsalan;
    • Pearce, Adam;
    • Rhee, Handoo;
    • Kyle, Samuel;
    • Raveenthiran, Sheliyan;
    • Wong, David;
    • McBean, Rhiannon;
    • Marsh, Phillip;
    • Goodman, Steven;
    • Dhiantravan, Nattakorn;
    • Esler, Rachel;
    • Dunglison, Nigel;
    • Navaratnam, Anojan;
    • Yaxley, John;
    • Thomas, Paul;
    • Pattison, David A.;
    • Goh, Jeffrey C.;
    • Gan, Chun Loo;
    • Roberts, Matthew J.
    Publication type:
    Article
    15
    16

    Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 9, p. 3289, doi. 10.1007/s00259-022-05756-2
    By:
    • Roberts, Matthew J.;
    • Morton, Andrew;
    • Papa, Nathan;
    • Franklin, Anthony;
    • Raveenthiran, Sheliyan;
    • Yaxley, William J.;
    • Coughlin, Geoffrey;
    • Gianduzzo, Troy;
    • Kua, Boon;
    • McEwan, Louise;
    • Wong, David;
    • Delahunt, Brett;
    • Egevad, Lars;
    • Samaratunga, Hemamali;
    • Brown, Nicholas;
    • Parkinson, Robert;
    • Emmett, Louise;
    • Yaxley, John W.
    Publication type:
    Article
    17
    18

    Prospective intra-individual blinded comparison of [<sup>18</sup>F]PSMA-1007 and [<sup>68</sup> Ga]Ga-PSMA-11 PET/CT imaging in patients with confirmed prostate cancer.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 2, p. 763, doi. 10.1007/s00259-021-05520-y
    By:
    • Pattison, David A.;
    • Debowski, Maciej;
    • Gulhane, Brook;
    • Arnfield, Evyn G.;
    • Pelecanos, Anita M.;
    • Garcia, Peter L.;
    • Latter, Melissa J.;
    • Lin, Charles Y.;
    • Roberts, Matthew J.;
    • Ramsay, Stuart C.;
    • Thomas, Paul A.
    Publication type:
    Article
    19
    20
    21

    68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 2, p. 477, doi. 10.1007/s00259-020-04944-2
    By:
    • Roberts, Matthew J.;
    • Morton, Andrew;
    • Donato, Peter;
    • Kyle, Samuel;
    • Pattison, David A.;
    • Thomas, Paul;
    • Coughlin, Geoff;
    • Esler, Rachel;
    • Dunglison, Nigel;
    • Gardiner, Robert A.;
    • Doi, Suhail A.;
    • Emmett, Louise;
    • Yaxley, John
    Publication type:
    Article
    22
    23

    Improved specificity with <sup>68</sup>Ga PSMA PET/CT to detect clinically significant lesions “invisible” on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 1, p. 20, doi. 10.1007/s00259-018-4160-7
    By:
    • Donato, Peter;
    • Coughlin, Geoff;
    • Esler, Rachel;
    • Dunglison, Nigel;
    • Roberts, Matthew J.;
    • Yaxley, John;
    • Gardiner, Robert A.;
    • Morton, Andrew;
    • Kyle, Samuel
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    41
    42
    43

    Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics.

    Published in:
    BJU International, 2024, v. 134, p. 47, doi. 10.1111/bju.16482
    By:
    • Roberts, Matthew J.;
    • Papa, Nathan;
    • Veerman, Hans;
    • de Bie, Katelijne;
    • Morton, Andrew;
    • Franklin, Anthony;
    • Raveenthiran, Sheliyan;
    • Yaxley, William J.;
    • Donswijk, Maarten L.;
    • van der Poel, Henk G.;
    • Samaratunga, Hemamali;
    • Wong, David;
    • Brown, Nicholas;
    • Parkinson, Robert;
    • Gianduzzo, Troy;
    • Kua, Boon;
    • Coughlin, Geoffrey D.;
    • Oprea‐Lager, Daniela E.;
    • Emmett, Louise;
    • van Leeuwen, Pim J.
    Publication type:
    Article
    44
    45
    46
    47

    Synchronous vs independent reading of prostate‐specific membrane antigen positron emission tomography (PSMA‐PET) and magnetic resonance imaging (MRI) to improve diagnosis of prostate cancer.

    Published in:
    BJU International, 2023, v. 131, n. 5, p. 588, doi. 10.1111/bju.15929
    By:
    • Doan, Paul;
    • Counter, William;
    • Papa, Nathan;
    • Sheehan‐Dare, Gemma;
    • Ho, Bao;
    • Lee, Jonathan;
    • Liu, Victor;
    • Thompson, James E.;
    • Agrawal, Shikha;
    • Roberts, Matthew J.;
    • Buteau, James;
    • Hofman, Michael S.;
    • Moon, Daniel;
    • Lawrentschuk, Nathan;
    • Murphy, Declan;
    • Stricker, Phillip D.;
    • Emmett, Louise
    Publication type:
    Article
    48
    49

    Event-free survival after radical prostatectomy according to prostate-specific membrane antigenpositron emission tomography and European Association of Urology biochemical recurrence risk groups.

    Published in:
    BJU International, 2022, v. 130, p. 32, doi. 10.1111/bju.15762
    By:
    • Roberts, Matthew J.;
    • Chatfield, Mark D.;
    • Hruby, George;
    • Nandurkar, Rohan;
    • Roach, Paul;
    • Watts, Jo Anne;
    • Cusick, Thomas;
    • Kneebone, Andrew;
    • Eade, Thomas;
    • Bao Ho;
    • Nguyen, Andrew;
    • Tang, Colin;
    • McCarthy, Michael;
    • Francis, Roslyn;
    • Stricker, Phillip;
    • Emmett, Louise
    Publication type:
    Article
    50